5MP-15644-88159
2 vaccinations
5 coded responses
9 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 160 / PA
- Registered
- 2022-08-02
- Relationship
- Child or adolescent in my care
- Guardian
- QTK-20036-56619
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-29
Dose 1 — Pfizer-BioNTech
-
2022-07-27
Dose 2 — Pfizer-BioNTech
-
2022-08-02
Registered in v-safe
-
2022-08-02
Survey response — days 1–6 daily, dose 2, under 3MedDRA: Nausea — Feeling: Poor · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to do your normal daily activitiesFree text: NauseaMedDRA releases: 2024-11 · check-in free text available
-
2022-08-03
Health check-in — day 7, dose 2, under 3Feeling: Fair · Fever · Sleepiness, Irritability/crying, Loss of appetite · Be unable to work or attend school, Be unable to do your normal daily activitiesUnder 3 check-in
- 2022-08-10
- 2022-08-17
-
2022-08-24
Survey response — day 28, dose 2, under 3MedDRA: Cough — Feeling: FairFree text: Coughing Only @ NightMedDRA releases: 2024-11 · check-in free text available
-
2022-08-31
Survey response — day 35, dose 2, under 3MedDRA: Cough — Feeling: FairFree text: Non-Productive Cough Mainly Night Into MorningMedDRA releases: 2024-11 · check-in free text available
-
2022-09-07
Survey response — day 42, dose 2, under 3MedDRA: Cough, Eye discharge — Feeling: FairFree text: Non Productive Cough This Morning Slight Eye DrainageMedDRA releases: 2024-11 · check-in free text available
- 2022-10-26
-
2023-01-25
Survey response — 6 months, dose 2, under 3MedDRA: COVID-19, Diarrhoea, Ear pain, Influenza like illness, Nausea, Oropharyngeal pain, Productive cough, Pyrexia, Vomiting, Wheezing — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11
-
2023-01-25
Report sent to call center — 6 months, dose 2, under 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2023-01-26
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-29 | Pfizer-BioNTech | No |
| 2 | 2022-07-27 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 (Under 3) — days 1–6 daily, dose 2, under 3
Systemic reaction (other): Nausea
Release 12 (Under 3) — day 28, dose 2, under 3
Symptoms: Coughing Only @ Night
Release 12 (Under 3) — day 35, dose 2, under 3
Symptoms: Non-Productive Cough Mainly Night Into Morning
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Non Productive Cough This Morning Slight Eye Drainage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Ear pain | · | · | ✓ |
| SD | Eye discharge | · | · | ✓ |
| SD | Influenza like illness | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
| SRO | Nausea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release